China green-lights domestic Ebola shot for clinical trials

China has approved a locally developed Ebola vaccine from its Academy of Military Medical Sciences for clinical trials, state news agency Xinhua said Thursday, according to Reuters. Media reports say the trial could start later this month, which would make the vaccine the third Ebola shot tested in humans behind candidates from GlaxoSmithKline ($GSK) and Merck ($MRK)/NewLink Genetics ($NLNK). More